Not applicableStudy completedNCT04568954What this trial is testingTB-CAPT CORE Truenat TrialWho this might be right forTuberculosisDiagnoses Disease Foundation for Innovative New Diagnostics, Switzerland 3,987
Large-scale testing (Phase 3)Looking for participantsNCT04260477What this trial is testingNovel Triple-dose Tuberculosis Retreatment RegimenWho this might be right forMultidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more Institute of Tropical Medicine, Belgium 370
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664What this trial is testingInnovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese CohortWho this might be right forRifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more Beijing Chest Hospital 120
Not applicableStudy completedNCT07058233What this trial is testingOral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical TrialWho this might be right forTuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb RSUP Persahabatan 70
Testing effectiveness (Phase 2)UnknownNCT01994460What this trial is testingLinezolid Instead of Ethambutol in Treatment of Drug-susceptible TuberculosisWho this might be right forPulmonary Tuberculosis Without Resistance to Rifampicin Seoul National University Hospital 429
Large-scale testing (Phase 3)Looking for participantsNCT07209761What this trial is testingQuabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisWho this might be right forPulmonary Tuberculosis Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Not applicableStudy completedNCT00000796What this trial is testingA Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.Who this might be right forHIV InfectionsTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 525
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721What this trial is testingInnovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortWho this might be right forDrug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis Huashan Hospital 120
Post-approval studies (Phase 4)Looking for participantsNCT06476210What this trial is testingThe Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Who this might be right forPulmonary Tuberculosis Beijing Chest Hospital 45
Large-scale testing (Phase 3)Study completedNCT00933790What this trial is testingComparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary TuberculosisWho this might be right forHIV InfectionPulmonary TB Tuberculosis Research Centre, India 331
Large-scale testing (Phase 3)Looking for participantsNCT06441006What this trial is testingProgram for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR University of California, San Francisco 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT06526039What this trial is testingA Short Regimen for Rifampicin-resistant Isoniazid-susceptible TBWho this might be right forTuberculosis, Pulmonary Taipei Medical University WanFang Hospital 100
Post-approval studies (Phase 4)Study completedNCT02231229What this trial is testingRapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment InitiationWho this might be right forTuberculosis Assistance Publique - Hôpitaux de Paris 204
Not applicableUnknownNCT05017324What this trial is testingSequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment TrialWho this might be right forRifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more Universiteit Antwerpen 248
Testing effectiveness (Phase 2)Ended earlyNCT05971602What this trial is testingEfficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary TuberculosisWho this might be right forPulmonary Tuberculosis Gates Medical Research Institute 93
Testing effectiveness (Phase 2)Looking for participantsNCT07170800What this trial is testingA Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWho this might be right forTuberculosisMultidrug Resistant Pulmonary TuberculosisRifampicin-resistant Tuberculosis WestVac Biopharma Co., Ltd. 60
Not applicableNot Yet RecruitingNCT07191834What this trial is testingA Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary TuberculosisWho this might be right forRifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid Wuhan Pulmonary Hospital 60
Large-scale testing (Phase 3)Study completedNCT02342886What this trial is testingShortening Treatment by Advancing Novel DrugsWho this might be right forTuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant Global Alliance for TB Drug Development 284
Large-scale testing (Phase 3)Looking for participantsNCT05824871What this trial is testingA Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis PatientsWho this might be right forRifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB) Shanghai Jiatan Pharmatech Co., Ltd 450
Early research (Phase 1)Not Yet RecruitingNCT06701136What this trial is testingDrug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese AdultsWho this might be right forRifampicin-Resistant Pulmonary Tuberculosis Patients Shanghai Jiatan Pharmatech Co., Ltd 16